Literature DB >> 369889

Pituitary adenoma and oral contraceptives: a case-control study.

C B Coulam, J F Annegers, C F Abboud, E R Laws, L T Kurland.   

Abstract

A search of the centralized data resource available at the Mayo Clinic for all cases of pituitary adenoma diagnosed in the population of Olmstead County, Minnesota, disclosed an increasing incidence of this tumor in women of childbearing age. The sex, age, and temporal relationships suggest that, if this increase is real, oral contraceptives should be considered as one of the possible etiologic factors. A case-control study, however, did not reveal an association of prior use of oral contraceptives with pituitary tumor--relative risk, 0.5; 95% confidence interval, 0.1 to 2.2. No association was found with other possible risk factors, i.e., prior head injury, radiation therapy, seizures, and smoking. Thus, unless other etiologic agents can be identified, it appears that the increasing incidence is due to advances in diagnostic and surgical technology rather than to a specific etiologic factor.

Entities:  

Keywords:  Amenorrhea; Americas; Biology; Cancer--etiology; Contraception; Contraceptive Methods--side effects; Data Collection; Developed Countries; Diseases; Endocrine System; Family Planning; Minnesota; Neoplasms; North America; Northern America; Oral Contraceptives--side effects; Physiology; Pituitary Gland; Prolactin; Research Methodology; Smoking; Surgery; United States

Mesh:

Substances:

Year:  1979        PMID: 369889     DOI: 10.1016/s0015-0282(16)43754-4

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

1.  Prolactinoma in a man following industrial exposure to estrogens.

Authors:  S H Baron; J R Sowers; M Feinberg
Journal:  West J Med       Date:  1983-05

2.  Oral contraceptives and pituitary adenomas.

Authors:  S J Wingrave; C R Kay; M P Vessey
Journal:  Br Med J       Date:  1980-03-08

3.  Oral Contraceptive and Menopausal Hormone Therapy Use and Risk of Pituitary Adenoma: Cohort and Case-Control Analyses.

Authors:  David J Cote; John L Kilgallon; Noah L A Nawabi; Hassan Y Dawood; Timothy R Smith; Ursula B Kaiser; Edward R Laws; JoAnn E Manson; Meir J Stampfer
Journal:  J Clin Endocrinol Metab       Date:  2022-03-24       Impact factor: 5.958

4.  Changes in the Options for Management of Prolactin Secreting Pituitary Adenomas.

Authors:  Sherry L Iuliano; Wenya Linda Bi; Edward R Laws
Journal:  J Neurol Surg B Skull Base       Date:  2021-02-18

5.  Alcohol intake and risk of pituitary adenoma.

Authors:  David J Cote; Timothy R Smith; Ursula B Kaiser; Edward R Laws; Meir J Stampfer
Journal:  Cancer Causes Control       Date:  2022-01-04       Impact factor: 2.532

6.  Primary intracranial tumors. Survey of incidence in the province of Trento in the years 1977-1981.

Authors:  G Ferrari; M G Lovaste; M Moresco; G Rossi
Journal:  Ital J Neurol Sci       Date:  1985-06

7.  Body Habitus Across the Lifespan and Risk of Pituitary Adenoma.

Authors:  David J Cote; Timothy R Smith; Ursula B Kaiser; Edward R Laws; Meir J Stampfer
Journal:  J Clin Endocrinol Metab       Date:  2021-03-25       Impact factor: 5.958

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.